Lishuo S. Shi - Publications

Neoadjuvant mFOLFOXIRI with or without cadonilimab versus mFOLFOX6 in locally advanced colorectal cancer: A randomized phase 2 trial (OPTICAL-2).

Journal: Med (New York, N.Y.)

Published: March 11, 2026

Neoadjuvant toripalimab plus celecoxib versus toripalimab monotherapy for mismatch repair-deficient or microsatellite instability-high, locally advanced colorectal cancer (PICC-2): an open-label, multicentre, randomised, phase 2 trial.

Journal: The Lancet. Oncology

Published: February 25, 2026

ASO Visual Abstract: Clinical Benefit and Cost-Effectiveness of FOLFOX Versus LCCRT in Neoadjuvant Treatment for Patients With Locally Advanced Rectal Cancer: An Economic Analysis of the FOWARC and PROSPECT Trials.

Journal: Annals of surgical oncology

Published: February 13, 2026

Cetuximab plus capecitabine every three weeks as first-line maintenance therapy for RAS/BRAF wild-type metastatic colorectal cancer: a phase Ib dose-escalation study.

Journal: NPJ precision oncology

Published: January 09, 2026

Association of multidisciplinary team management with survival in sinonasal malignancies: a real-world IPTW cohort study.

Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery

Published: December 23, 2025

Combined Upadacitinib and Vedolizumab as 8-Week Induction Therapy for Moderate-to-Severe Ulcerative Colitis: A Multicenter, Randomized Controlled Trial.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: November 19, 2025

Association of Musculoskeletal Pain With Foot Type, Plantar Pressure, Physical Activity, Psychosocial Factors, and Daily Living Habits Among Adolescents.

Journal: Clinical medicine insights. Arthritis and musculoskeletal disorders

Published: November 13, 2025

Neoadjuvant PD-1 blockade with toripalimab with or without celecoxib for patients with mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): long-term outcomes of a single-centre, parallel-group, non-comparative, randomised phase 2 trial.

Journal: EClinicalMedicine

Published: July 28, 2025

Short-term outcomes of endoscopic intermuscular dissection for early rectal cancer with deep submucosal infiltration: a single-center experience from China.

Journal: Techniques in coloproctology

Published: May 19, 2025

Oncological Outcomes of Intersphincteric Resection Versus Abdominoperineal Resection for ypT3 Low Rectal Cancer After Neoadjuvant Chemoradiotherapy: A Multicenter Retrospective Analysis.

Journal: Diseases of the colon and rectum

Published: May 07, 2025

Creeping fat is associated with transmural healing in patients with Crohn's disease receiving ustekinumab.

Journal: Insights into imaging

Published: April 27, 2025

Reply to: Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Omission of Radiotherapy or Not?

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: April 24, 2025